Screener
Gilead Sciences GILD Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000882095-26-000031
| (in millions, except per share amounts) | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Product sales | $7,627 | $7,054 | $14,574 | $13,668 |
| Royalty, contract and other revenues | 176 | 27 | 189 | 81 |
| Total revenues | 7,803 | 7,082 | 14,763 | 13,749 |
| Costs and expenses: | ||||
| Cost of goods sold | 1,579 | 1,501 | 3,023 | 3,041 |
| Research and development expenses | 1,764 | 1,491 | 3,136 | 2,870 |
| Acquired in-process research and development expenses | 11,183 | 61 | 11,290 | 315 |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Gilead Sciences's total revenue?
- Gilead Sciences (GILD) reported total revenue of $7.8B in Q2 2026.
- How has Gilead Sciences's total revenue changed year-over-year?
- Gilead Sciences's total revenue increased by 10.2% year-over-year, from $7.08B to $7.8B.
- What is the long-term trend for Gilead Sciences's total revenue?
- Over 4 years (2021 to 2025), Gilead Sciences's total revenue has grown at a 1.9% compound annual growth rate (CAGR), from $27.31B to $29.44B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Gilead Sciences's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude